US4194010AExpiredUtility

Pharmacologically active enol ether compounds

Assignee: BEECHAM GROUP LTDPriority: Oct 29, 1975Filed: Jun 2, 1978Granted: Mar 18, 1980
Est. expiryOct 29, 1995(expired)· nominal 20-yr term from priority
C07D 317/20C07C 43/215C07C 43/315
46
PatentIndex Score
1
Cited by
5
References
12
Claims

Abstract

Acetals, enol acylates and enol ethers of the compound of the compound of the formula (I): ##STR1## notionally derivable from a C 1-8 alcohol or C 1-8 acid are useful anti-inflammatory agents.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. An enol ether of the formula (II) or (III): ##STR5## in each of which formulas R 1  is alkyl of 2-4 carbon atoms. 
     
     
       2. An enol ether of claim 1 of the formula (II): ##STR6## in which R 1  is alkyl of 2-4 carbon atoms. 
     
     
       3. An enol ether of claim 1 of the formula (III): ##STR7## in which R 1  is alkyl of 2-4 carbon atoms. 
     
     
       4. An enol ether according to claim 1 in which R 1  is ethyl or propyl. 
     
     
       5. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 1 in combination with a pharmaceutically acceptable carrier. 
     
     
       6. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 2 in combination with a pharmaceutically acceptable carrier. 
     
     
       7. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 3 in combination with a pharmaceutically acceptable carrier. 
     
     
       8. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 4 in combination with a pharmaceutically acceptable carrier. 
     
     
       9. A pharmaceutical composition according to claim 5 in oral unit dosage form. 
     
     
       10. A method of treating inflammation which comprises administering an anti-inflammatory amount of a composition of claim 5. 
     
     
       11. A method according to claim 10 in which the administration is oral. 
     
     
       12. A method according to claim 10 in which the administration is oral and the composition is in unit dosage form.

Join the waitlist — get patent alerts

Track US4194010A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.